Manipal Health IPO Review: Everything You Need to Know
The Manipal Health IPO is one of India’s biggest healthcare IPOs, raising ₹9,275 crore through a combination of a fresh issue and an Offer for Sale (OFS). With a strong hospital network, consistent revenue growth, and expansion plans, the IPO has attracted significant investor interest. However, its premium valuation and debt levels make it important to evaluate both the opportunities and risks before investing.
If you’re wondering whether you should apply for the Manipal Health IPO, this guide breaks down the company’s business, financial performance, valuation, risks, and long-term outlook.
Manipal Health IPO Snapshot
| Particular | Details |
|---|---|
| IPO Size | ₹9,275.22 crore |
| Fresh Issue | ₹8,000 crore |
| Offer for Sale | ₹1,275.22 crore |
| Price Band | ₹560 to ₹590 |
| Face Value | ₹2 |
| Lot Size | 25 shares |
| Listing | NSE & BSE |
| Issue Type | Book Built Issue |
The IPO opened on 29 July 2026 and closes on 31 July 2026, with the proposed listing scheduled for 5 August 2026.
About Manipal Health
Founded in 1991, Manipal Health Enterprises is among India’s largest private healthcare providers. The company operates a network of multi-specialty hospitals offering tertiary and quaternary care across major Indian cities.
Its hospitals provide services including:
- Cardiology
- Oncology
- Neurosciences
- Orthopaedics
- Organ Transplants
- Gastroenterology
- Women’s & Child Care
- Critical Care
The company has expanded significantly through acquisitions, making it one of India’s largest hospital chains by licensed bed capacity.
Why Is Manipal Health Launching an IPO?
The IPO is not solely for raising growth capital.
A major portion of the fresh issue proceeds will be used to reduce debt accumulated through acquisitions and strengthen the balance sheet. The remaining funds will support expansion and general corporate purposes. Around 77% of the fresh issue is earmarked for debt repayment related to acquisitions.
Business Strengths
1. Strong Brand Recognition
Manipal Hospitals has built a trusted healthcare brand over several decades, especially in South India.
2. Diversified Hospital Network
The company operates hospitals across multiple cities, reducing dependence on a single geography.
3. Growing Healthcare Demand
India’s healthcare spending continues to rise because of:
- Ageing population
- Lifestyle diseases
- Better health insurance penetration
- Higher disposable incomes
- Growing medical tourism
These long-term trends support hospital operators like Manipal Health.
4. High Occupancy and Premium Services
Manipal focuses on complex procedures that generally generate higher revenue per patient than basic healthcare services.
Financial Performance
The company has demonstrated strong growth over the last three financial years.
| Financial Year | Revenue | PAT |
|---|---|---|
| FY24 | ₹6,265 crore | ₹533 crore |
| FY25 | ₹8,363 crore | ₹1,082 crore |
| FY26 | ₹10,336 crore | ₹905 crore |
Revenue has grown rapidly over this period, although profit declined in FY26 due to higher taxes and acquisition integration costs.
Key Positives
- Strong revenue growth
- Healthy EBITDA margins
- Improving operating efficiencies
- Large patient base
- Consistent cash generation
Industry Outlook
India’s healthcare industry is expected to benefit from multiple structural trends:
- Increasing healthcare expenditure
- Rising health insurance penetration
- Expansion into Tier II and Tier III cities
- Growing medical tourism
- Demand for specialty healthcare
Private hospitals are expected to remain one of the fastest-growing segments within India’s healthcare ecosystem.
Valuation Analysis
One of the biggest concerns surrounding the IPO is valuation.
Based on FY26 earnings, the IPO is valued at approximately 76 times earnings, placing it at the premium end of listed hospital companies.
A premium valuation means investors are paying today for expected future growth.
This can work well if:
- Earnings continue growing rapidly
- Expansion succeeds
- Debt reduces significantly
- Margins improve further
However, any slowdown could impact stock performance.
Risks Investors Should Know
1. High Valuation
The IPO is priced aggressively compared to current earnings.
2. Integration Risk
The company has expanded rapidly through acquisitions.
Integrating multiple hospital chains is operationally challenging.
3. Regulatory Risk
Healthcare remains highly regulated.
Changes in pricing rules, insurance reimbursement, or government policies could affect profitability.
4. Competition
Major listed competitors include:
- Apollo Hospitals
- Max Healthcare
- Fortis Healthcare
- Narayana Health
Competition for doctors and premium patients remains intense.
Grey Market Premium (GMP)
Early market sentiment has remained relatively subdued, with reports indicating only a small Grey Market Premium (GMP), suggesting cautious expectations for listing gains. Investors should remember that GMP is unofficial and should not be the sole basis for an investment decision.
Should You Apply for the Manipal Health IPO?
Investors seeking listing gains
The muted GMP suggests expectations for immediate listing gains are modest.
Long-term investors
The IPO may appeal to investors who believe in India’s long-term healthcare growth story and are comfortable with a premium valuation.
Conservative investors
Those sensitive to valuation may prefer to watch the company’s post-listing performance before investing.
Final Verdict
Manipal Health is entering the stock market as one of India’s leading hospital chains with a strong brand, expanding network, and solid revenue growth. The company stands to benefit from long-term structural growth in India’s healthcare sector, and the IPO proceeds should help strengthen its balance sheet through debt reduction.
On the other hand, investors should carefully weigh the premium valuation, integration risks from acquisitions, and competitive landscape. For long-term investors with a positive view on India’s healthcare industry, the IPO could be worth considering. Those focused primarily on short-term listing gains may find the risk-reward less compelling given current market sentiment.
Frequently Asked Questions
Q. Is Manipal Health IPO good for long-term investment?
It may be suitable for long-term investors who believe in India’s growing healthcare sector and are comfortable with premium valuations.
Q. What will the IPO proceeds be used for?
The company plans to primarily reduce debt, fund expansion, and support general corporate purposes.
Q. Who are Manipal Health’s competitors?
Major competitors include Apollo Hospitals, Max Healthcare, Fortis Healthcare, and Narayana Health.
Q. Is GMP a reliable indicator?
No. GMP reflects unofficial market sentiment and should not be considered a guarantee of listing performance.
Key Takeaways
- Manipal Health is one of India’s largest private hospital chains.
- The IPO size is ₹9,275.22 crore.
- Most fresh issue proceeds will be used for debt reduction.
- Revenue has grown strongly over the past three years.
- The IPO is priced at a premium valuation.
- Long-term healthcare demand remains a strong growth driver.
- Investors should balance growth prospects against valuation and execution risks.
Disclaimer
The stocks mentioned in this article are not recommendations. Please conduct your own research and due diligence before investing. Investment in securities market are subject to market risks, read all the related documents carefully before investing. Please read the Risk Disclosure documents carefully before investing in Equity Shares, Derivatives, Mutual fund, and/or other instruments traded on the Stock Exchanges. As investments are subject to market risks and price fluctuation risk, there is no assurance or guarantee that the investment objectives shall be achieved. Lemonn (Formerly known as NU Investors Technologies Pvt. Ltd) do not guarantee any assured returns on any investments. Past performance of securities/instruments is not indicative of their future performance.
